`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`___________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________
`
`
` COALITION FOR AFFORDABLE DRUGS V LLC;
`HAYMAN CREDES MASTER FUND, L.P.;
`HAYMAN ORANGE FUND SPC – PORTFOLIO A;
`HAYMAN CAPITAL MASTER FUND, L.P.;
`HAYMAN CAPITAL MANAGEMENT, L.P.;
`HAYMAN OFFSHORE MANAGEMENT, INC.;
`HAYMAN INVESTMENTS, LLC;
`NXN PARTNERS, LLC;
`IP NAVIGATION GROUP, LLC;
`J KYLE BASS, and ERICH SPANGENBERG,
`Petitioner,
`
`v.
`
`BIOGEN MA INC.,
`Patent Owner.
`____________________________________________
`
` Case IPR2015-01993
`Patent 8,399,514 B2
` ____________________________________________
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(2), Patent Owner Biogen MA Inc. provides
`
`U.S. Patent No. 8,399,514
`Case: IPR2015-01993
`
`the following updated mandatory notices.
`
`Although there has been no change to the identity of related proceedings
`
`previously provided in section II, Patent Owner has updated the status of related
`
`IPR2015-01136 to reflect that the Board denied Petitioner’s request for rehearing.
`
`In addition, sections III and IV have been updated to reflect the appearance
`
`of Erin M. Sommers as back-up counsel for Patent Owner on March 28, 2016.
`
`I.
`
`Real Party-in-Interest - 37 C.F.R. § 42.8(b)(1)
`
`The real party-in-interest is Biogen MA Inc., the owner of U.S. Patent No.
`
`8,399,514. A corporate name change document was recorded in the U.S. Patent
`
`and Trademark Office on April 27, 2015 (reel 35507/frame 541) and May 4, 2015
`
`(reel 35571/frame 926). Those documents changed the corporate name from
`
`Biogen Idec MA Inc. to Biogen MA Inc. The original assignment to Biogen Idec
`
`MA Inc. of U.S. patent application No. 13/372,426 that led to U.S. Patent No.
`
`8,399,514 was recorded in the Office on May 3, 2012, at reel 28146, frame 980.
`
`II. Related Matters – 37 C.F.R. § 42.8(b)(2)
`Interference No. 106,023 (McK), involving U.S. Patent No. 8,399,514, was
`
`declared between Biogen MA Inc. and Forward Pharma A/S on April 13, 2015.
`
`
`
`IPR2015-01136 involving the same ’514 patent was filed by the same
`
`Petitioner as the instant petition. The Board denied institution of an IPR in that
`
`
`
`2
`
`
`
`
`
`
`proceeding on September 2, 2015, and Petitioner filed a request for rehearing on
`
`U.S. Patent No. 8,399,514
`Case: IPR2015-01993
`
`October 2, 2015. The Board denied Petitioner’s request for a rehearing on October
`
`23, 2015.
`
`U.S. Application Nos. 13/767,014 (abandoned), 13/804,283 (pending), and
`
`14/718,962 (pending) claim benefit of priority to the application that issued as U.S.
`
`Patent No. 8,399,514. Patent Owner is not aware of any other related matters that
`
`would affect or be affected by this proceeding.
`
`III. Lead and Back-Up Counsel – 37 C.F.R. § 42.8(b)(3)
`Further to the submission of the notice of appearance of Erin M. Sommers as
`
`counsel for Patent Owner (Paper 22) and pursuant to 37 C.F.R. §§ 42.8(a)(3) and
`
`42.8(b)(3)-(4), Patent Owner designates the following counsel to transact all
`
`business in the United States Patent and Trademark Office associated with the
`
`above-captioned proceeding.
`
`Lead Counsel
`Michael J. Flibbert (Reg. No. 33,234)
`
`Back-Up Counsel
`Maureen D. Queler (Reg. No. 61,879)
`
`Finnegan, Henderson, Farabow, Garrett
`
`Finnegan, Henderson, Farabow, Garrett
`
`& Dunner, LLP
`
`& Dunner, LLP
`
`901 New York Avenue, N.W.
`
`901 New York Avenue, N.W.
`
`Washington, D.C. 20001-4431
`
`Washington, D.C. 20001-4431
`
`Telephone: (202) 408-4493
`
`Telephone: (202) 408-4294
`
`
`
`3
`
`
`
`U.S. Patent No. 8,399,514
`Case: IPR2015-01993
`
`Fax: (202) 408-4400
`
`Fax: (202) 408-4400
`
`Email: michael.flibbert@finnegan.com
`
`Email: maureen.queler@finnegan.com
`
`Back-Up Counsel
`
`Erin M. Sommers (Reg. No. 60,974)
`
`Finnegan, Henderson, Farabow, Garrett
`
`& Dunner, LLP
`
`901 New York Avenue, NW
`
`Washington, DC 20001-4413
`
`Email: erin.sommers@finnegan.com
`
`Phone: (202) 408-4292
`
`Fax: (202) 408-4400
`
`
`
`
`
`
`
`
`
`IV. Service Information – 37 C.F.R. § 42.8(b)(4)
`Please send all correspondence to the lead counsel at the address shown
`
`above. Under 37 C.F.R. § 42.6(e), Patent Owner consents to electronic service by
`
`
`to michael.flibbert@finnegan.com, maureen.queler@finnegan.com,
`
`erin.sommers@finnegan.com, and biogenidecptab-all@finnegan.com.
`
`Please address all correspondence regarding this proceeding to lead and
`
`back-up counsel.
`
`
`
`
`
`4
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: April 8, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`U.S. Patent No. 8,399,514
`Case: IPR2015-01993
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`By: /Michael J. Flibbert/
`Michael J. Flibbert, Reg. No. 33,234
`Maureen D. Queler, Reg. No. 61,879
`Erin M. Sommers, Reg. No. 60,974
`Finnegan, Henderson, Farabow,
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`(202) 408-4000
`
`Counsel for Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`U.S. Patent No. 8,399,514
`Case: IPR2015-01993
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that copies of the foregoing PATENT
`
`OWNER’S UPDATED MANDATORY NOTICES was served on April 8, 2016,
`
`via electronic mail directed to counsel of record for the Petitioner at the following:
`
`Robert W. Hahl
`Robert Mihail
`John K. Pike
`Neifeld IP Law, PC,
`4813-B Eisenhower Avenue
`Alexandria, VA 22304
`rhahl@neifeld.com
`rmihail@neifeld.com
`jkpike@neifeld.com
`general@neifeld.com
`
`James T. Carmichael
`Carmichael IP, PLLC
`8000 Towers Crescent Drive, 13th Floor
`Tysons Corner, VA 22182
`jim@carmichaelip.com
`
`Petitioner has agreed to electronic service.
`
`
`Dated: April 8, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`By: /Erin M. Sommers/
`Erin M. Sommers, Reg. No. 60,974
`
`FINNEGAN, HENDERSON,
`FARABOW, GARRETT &
`
`DUNNER, LLP
`
`
`
`